8.9% Increase in Pain Medication Sales Since 2005

According to a news release by Reportlinker, the global market in pain medications logged $22 billion in sales in 2010, rising at a compound annual growth rate of 8.9 percent since 2005. The growth was dominated by five blockbuster pain drugs: OxyContin, Lyrica, Cymbalta and Lidoderm.

Advertisement

Click here for the full Becker’s ASC Review report on the pain medication market.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.